The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
- PMID: 32973925
- PMCID: PMC7495942
- DOI: 10.1177/1756284820941745
The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
Abstract
In recent years, the human gut microbiome has been found to influence a multitude of non-communicable diseases such as cardiovascular disease and metabolic syndrome, with its components type 2 diabetes mellitus and obesity. It is recognized to be mainly influenced by environmental factors, such as lifestyle, but also genetics may play a role. The interaction of gut microbiota and obesity has been widely studied, but in regard to non-alcoholic fatty liver disease (NAFLD) as a manifestation of obesity and insulin resistance, the causal role of the gut microbiome has not been fully established. The mechanisms by which the gut microbiome influences lipid accumulation, inflammatory responses, and occurrence of fibrosis in the liver are a topic of active research. In addition, the influence of exercise on gut microbiome composition is also being investigated. In clinical trials, exercise reduced hepatic steatosis independently of weight reduction. Other studies indicate that exercise may modulate the gut microbiome. This puts forward the question whether exercise could mediate its beneficial effects on NAFLD via changes in gut microbiome. Yet, the specific mechanisms underlying this potential connection are largely unknown. Thus, associative evidence from clinical trials, as well as mechanistic studies in vivo are called for to elucidate the relationship between exercise and the gut microbiome in NAFLD. Here, we review the current literature on exercise and the gut microbiome in NAFLD.
Keywords: exercise; gut microbiome; insulin resistance; non-alcoholic fatty liver disease; obesity; type 2 diabetes mellitus.
© The Author(s), 2020.
Conflict of interest statement
Conflict of interest statement: MN is on the Scientific Advisory Board of Caelus Health, The Netherlands, and Kaleido Biosciences, USA. However, none of these possible conflicts of interest bear direct relation to the manuscript.
Figures
References
-
- World Health Organization. Global health risks, http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_re... (2009, accessed 11 November 2019).
-
- Younossi ZM, Golabi P, De Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 2019; 71: 793–801. - PubMed
-
- Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73–84. - PubMed
-
- Bedossa P. Pathology of non-alcoholic fatty liver disease. Liver Int 2017; 37: 85–89. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical
